Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Regulus Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

14 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Regulus Therapeutics Inc (RGLS-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

18 May 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for RGLS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

15 May 2016 ValuEngine, Inc. 11 $25.00

REGULUS THERAPEUTICS INC (RGLS=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

14 May 2016 Pechala's Reports 2 $25.00

Regulus Therapeutics Inc. (RGLS) - Financial Analysis Review

Regulus Therapeutics Inc. (RGLS) - Financial Analysis Review Summary Regulus Therapeutics Inc. (Regulus Therapeutics) is a bi...

13 May 2016 GlobalData 58 $300.00

Value Graph: REGULUS THERAPEU -- RGLS

13 May 2016 Ford Investor Services, Inc. 1 $12.00

Wright Investors Service Comprehensive Report for Regulus Therapeutics Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

08 May 2016 Wright Reports 55 $75.00

RGLS.OQ - Event Transcript of Regulus Therapeutics Inc conference call, May 02, 2016 / 5:00PM ET

Edited Event Transcript of RGLS.OQ conference call, May 02, 2016 / 5:00PM ET Boston, May 5, 2016 (Thomson StreetEvents)...

02 May 2016 Thomson Reuters StreetEvents 14 $75.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of REGULUS THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

29 Apr 2016 Jefferson Research 11 $20.00

RGLS.OQ - Event Transcript of Regulus Therapeutics Inc conference call, Apr. 15, 2016 / 8:00AM ET

Edited Event Transcript of RGLS.OQ conference call, Apr. 15, 2016 / 8:00AM ET Boston, Apr 16, 2016 (Thomson StreetEvent...

15 Apr 2016 Thomson Reuters StreetEvents 13 $75.00